Skip to content

Anemia in Orthopedic Surgery - Determination of Hb

Prevalence of Anemia in Orthopedic Surgery, Data Collection From Classical Laboratory Determination of Hemoglobin, by Non-invasive Hemoglobin Measurement (Rad-67™) and by HemoCue®.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03328780
Enrollment
300
Registered
2017-11-01
Start date
2017-12-18
Completion date
2018-02-21
Last updated
2018-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia

Keywords

preoperative, orthopedic surgery

Brief summary

Anemia prevalence in orthopedic surgery is up to 30 %. Identifying those patients prior to surgery and treating them would be ideal. Different ways of determining hemoglobin Levels are available. In this study classical laboratory determination, determination with HemoCue® and Rad-67™ will be performed to compare precision of those three methods as well as their correlation.

Interventions

DEVICEHemocue and Rad-67 measurement

Measurement of the hemoglobin level

Sponsors

Theusinger Oliver M.
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Age \> 18 years * Scheduled for elective orthopedic surgery * Written informed consent.

Exclusion criteria

• Not able to speak the german language

Design outcomes

Primary

MeasureTime frameDescription
Precisionthrough study completion, an average of 1 yearPrecision of the Masimo Rad-67 versus standard hemoglobin determination in the laboratory and the Hemocue (Correlation, Standard deviation, possible significant differences).

Secondary

MeasureTime frameDescription
Anemiathrough study completion, an average of 1 yearPrevalence of anemia in elective orthopedic surgery

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026